Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure
Ibrahim, A., Ali, H., Ahmad, H., Mounir, M. (2020). Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure. EKB Journal Management System, 31(2), 193-195. doi: 10.21608/mjmr.2022.221009
Alaa M. Ibrahim; Hisham A. Ali; Hazem . M. A. Ahmad; Mena S. Mounir. "Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure". EKB Journal Management System, 31, 2, 2020, 193-195. doi: 10.21608/mjmr.2022.221009
Ibrahim, A., Ali, H., Ahmad, H., Mounir, M. (2020). 'Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure', EKB Journal Management System, 31(2), pp. 193-195. doi: 10.21608/mjmr.2022.221009
Ibrahim, A., Ali, H., Ahmad, H., Mounir, M. Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure. EKB Journal Management System, 2020; 31(2): 193-195. doi: 10.21608/mjmr.2022.221009

Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure

Minia Journal of Medical Research
Volume 31, Issue 2, April 2020, Page 193-195  XML PDF (239.47 K)
Document Type: Original Article
DOI: 10.21608/mjmr.2022.221009
View on SCiNiTO View on SCiNiTO
Authors
Alaa M. Ibrahim1; Hisham A. Ali2; Hazem . M. A. Ahmad3; Mena S. Mounir3
1Department of Cardiology, Faculty of Medicine, Minia University
2Department of Internal medicine, Faculty of Medicine, Minia University.
3Department of Cardiology, Faculty of Medicine, Minia University.
Abstract
Introduction: Hepatitis C virus (HCV) infection is a persistent viral infection of the liver and 
considered as a considerable health dilemma globally especially in Egypt. Treatment for chronic 
hepatitis C virus infection is evolving from interferon (IFN)-based therapy to direct-acting antiviral 
(DAA) agents. Cardiovascular diseases (CVDs), which accounted for one-third of global deaths in 
2015, are recognized as a major barrier to sustainable human development. Aim of the work: The 
aim of this study is to evaluate the effect of new antiviral treatments regarding heart failure in patients 
with chronic viral hepatitis “c”. Patients and Methods: This cohort study was carried out on 100
patients with chronic heart failure and candidate for DAA therapy. Cases were taken and divided into: 
Results: The DAAs used in combination regimen with ribavirin do not significantly affect the 
cardiovascular system.

Keywords
DAA: direct acting antiviral therapy; HCV: hepatitis C virus; CVDs: cardiovascular diseases; CHF: chronic heart failure. 
Supplementary Files
Statistics
Article View: 52
PDF Download: 46